Related articles
Case Study: Accelerating CRO study deployment at scale
A top-3 contract research organization (CRO) and a top-10 pharmaceutical company partnered with Medable to help accelerate the speed, scale, and standardization of their eCOA trials.
The two organizations had been hampered by lengthy configuration timelines, inconsistent designs across studies, and siloed processes between sponsors and their CRO partners.
By centralizing the sponsor’s preferred instruments and configurations into a reusable digital library, Medable enabled the CRO to rapidly accelerate its portfolio development and initiate new studies without starting them “from scratch.”
Complete the form to get your copy of the case study and see how we enable rapid acceleration for CROs.
The Top 5 myths about eCOA in 2025
With MarketsandMarkets projecting the global electronic Clinical Outcome Assessments (eCOA) solutions market to grow at compound annual growth rate (CAGR) of 16.1% each year until 2030, it’s clear the eCOA has made its impact within the clinical research landscape.
Yet despite growing adoption, electronic Clinical Outcome Assessments (eCOA) are still surrounded by misconceptions that hinder their full potential. From concerns about patient usability to assumptions about cost and implementation timelines, these myths can create hesitation among sponsors and research teams alike.
Thus, we’re here to cut through the noise and set the record straight with a summary of a recent webinar featuring speakers from Transcelerate and Medable.
Accelerating oncology research: Digital strategies for modern clinical trials
Oncology research has been on a 20-year rise and is showing no signs of slowing down anytime in the future. Consider this, between 2000 and 2021, the amount of drugs targeting cancer quadrupled. In 2023, a separate research report found that over 2,000 new oncology clinical trials were launched just that year, and that global spending on cancer medicines “is projected to reach $409 billion by 2028.” Finally, as of May 2025, a search of ClinicalTrials.gov yielded over 39,500 studies indexed under terms including “neoplasm,” “cancer,” and “tumor,” encompassing diverse phases and global locations.